AD-11-VE17_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, (Z)-2-amino-4-methyl-5-phosphonopent-3-enoic acid, Kainate receptor antagonist targeting GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 (Novartis, 22290157)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/22290157
Similar Terms
Downloads & Tools

Genes

8 genes differentially expressed following the AD-11-VE17_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
SEMA4A sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A 0.925602
RPL37A ribosomal protein L37a 0.344563
PPDPF pancreatic progenitor cell differentiation and proliferation factor 0.343134
BUD31 BUD31 homolog (S. cerevisiae) 0.26945
NDUFB7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa 0.226967

decreased expression

Symbol Name Standardized Value
MLLT6 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 -0.60296
SMG1 SMG1 phosphatidylinositol 3-kinase-related kinase -0.26945
CSAG3 CSAG family, member 3 -0.236329